Sustained Remission Following Limited Dupilumab Exposure in Refractory Eosinophilic Esophagitis

Dain (Raina) Kim, Adam Bubelenyi, Milli Gupta

Open source

DOI
10.14309/crj.0000000000002314
Published
2026-09
Container
ACG Case Reports Journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14309/crj.0000000000002314,
  title = {Sustained Remission Following Limited Dupilumab Exposure in Refractory Eosinophilic Esophagitis},
  author = {Dain (Raina) Kim and Adam Bubelenyi and Milli Gupta},
  year = {2026},
  journal = {ACG Case Reports Journal},
  doi = {10.14309/crj.0000000000002314},
  url = {https://doi.org/10.14309/crj.0000000000002314}
}

RIS

TY  - JOUR
TI  - Sustained Remission Following Limited Dupilumab Exposure in Refractory Eosinophilic Esophagitis
AU  - Dain (Raina) Kim
AU  - Adam Bubelenyi
AU  - Milli Gupta
PY  - 2026
JO  - ACG Case Reports Journal
DO  - 10.14309/crj.0000000000002314
UR  - https://doi.org/10.14309/crj.0000000000002314
ER  - 

APA

Kim, D. (., Bubelenyi, A., & Gupta, M. (2026). Sustained Remission Following Limited Dupilumab Exposure in Refractory Eosinophilic Esophagitis. ACG Case Reports Journal. https://doi.org/10.14309/crj.0000000000002314

Source records